CMS Health Fraud Spotlight: the Done Telehealth Case
July 8, 2026 · CMSHHSgov · 0:02:36
Embedded from the source channel — never re-uploaded. Watch on YouTube
What happened
CMS launched its “Health Fraud Spotlight” video series on July 8, 2026, with an episode that calls its subject “a drug trade wrapped in telehealth.” According to the video, a federal jury convicted Ruthia He, founder of the digital health startup Done, and her clinical partner of distributing more than 40 million pills of Adderall and other stimulants through an online system the video describes as lacking real medical oversight — cursory assessments, pressure to prescribe, automatic refills without genuine clinical interaction, and prescriptions that in some cases continued despite complications.
The video stresses that He was no outsider to the system: it notes her Carnegie Mellon training, education in Beijing, and product roles at major technology companies including Facebook and Tencent, and argues that expertise was used to build a platform optimized for growth and revenue rather than patients.
Why it matters
The series is CMS packaging individual enforcement outcomes as public evidence for its broader fraud campaign — the same campaign as the “War on Fraud” film and the September 2026 ACA enrollment removals. A conviction, as opposed to an allegation, is the strongest form of that evidence, and the episode is careful to present this case as adjudicated.
Scoreboard watch
Candidate context for the fraud-crackdown scoreboard line: convictions secured in cases CMS publicizes are part of the outcome record, alongside the enrollment and dollar figures the agency states elsewhere.
Sources: CMSHHSgov (CMS official channel), “CMS Health Fraud Spotlight Ep. 1,” July 8, 2026 (official upload, embedded above). Case details as presented in the video.
On this page